Skip Navigation


Rheumatology Advance Access originally published online on November 30, 2005
Rheumatology 2006 45(2):228-229; doi:10.1093/rheumatology/kei173
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
45/2/228    most recent
kei173v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hocevar, A.
Right arrow Articles by Tomsic, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hocevar, A.
Right arrow Articles by Tomsic, M.
Related Collections
Right arrow Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

LETTER TO THE EDITOR

Leflunomide-associated tuberculosis?

A. Hocevar, B. Rozman, S. Praprotnik, B. Lestan, D. Erzen1, V. Petric2 and M. Tomsic

Department of Rheumatology, University Medical Centre, Ljubljana, 1 University Clinic of Respiratory and Allergic Diseases, Golnik and 2 Department of Internal Medicine, General Hospital, Murska Sobota, Slovenia

Correspondence to: M. Tomsic, Department of Rheumatology, University Medical Centre, Vodnikova 62, 1000 Ljubljana, Slovenia. E-mail: matija.tomsic@guest.arnes.si

The first 10% of the full text of this article appears below.

SIR, Tuberculosis (TB) is still one of the world's most frequently occurring infectious diseases. The incidence of active TB in Slovenia is 14.7 patients per 105 inhabitants [1]. In Spain, the risk of TB infection in rheumatoid arthritis (RA) patients is increased fourfold compared with the general Spanish population [2], which is not the case in the USA, a country with a low incidence of TB [3. . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
R. Grover, V. Dhir, R. Aneja, V. Arya, A. Galle, V. Marwaha, and A. Kumar
Severe infections following leflunomide therapy for Rheumatoid Arthritis
Rheumatology, July 1, 2006; 45(7): 918 - 920.
[Full Text] [PDF]